| 2026-08-05 | Press release | Biodesix Announces Second Quarter 2026 Results and Highlights |
| 2026-08-05 | 8-K | Form 8-K, Item 2.02 results |
| 2026-08-05 | 10-Q | Form 10-Q for the quarter ended Jun 30 |
| 2026-08-04 | Deck | Corporate Presentation |
| 2026-08-04 | Press release | Biodesix to Participate in Canaccord Genuity’s 46th Annual Growth Conference |
| 2026-07-22 | Press release | Biodesix to Report Second Quarter 2026 Financial Results on August 5, 2026 |
| 2026-05-21 | Press release | Biodesix to Participate in Upcoming Investor Conferences |
| 2026-05-20 | 8-K | Form 8-K, Item 5.07 |
| 2026-05-11 | Press release | Biodesix Announces ATS 2026 Presentations Providing Real-World Clinical Evidence and Healthcare System Economic Value fo |
| 2026-05-04 | Press release | Biodesix Announces First Quarter 2026 Results and Highlights |
| 2026-05-04 | 8-K | Form 8-K, Item 2.02 results |
| 2026-05-04 | 10-Q | Form 10-Q for the quarter ended Mar 31 |
| 2026-04-20 | Press release | Biodesix to Report First Quarter 2026 Financial Results on May 4, 2026 |
| 2026-04-09 | Press release | Biodesix Recognized as a Top Workplace for Third Consecutive Year |
| 2026-04-09 | Proxy | Definitive proxy statement |
| 2026-04-06 | Press release | Biodesix Announces AACR 2026 Posters and Presentations, Highlighting Novel Diagnostic Test Discovery & Pipeline Deve |
| 2026-03-20 | Press release | Biodesix Announces the Largest Lung Nodule Biomarker Clinical Validation Study Ever Published Supporting Earlier Lung Ca |
| 2026-03-01 | Transcript | Q4 FY25 earnings call transcript |
| 2026-02-26 | Press release | Biodesix Announces Fourth Quarter and Fiscal Year 2025 Results and Highlights |
| 2026-02-26 | 8-K | Form 8-K, Item 2.02 results |
| 2026-02-26 | 10-K | Annual report on Form 10-K, FY25 |
| 2026-02-24 | Press release | Biodesix to Participate in Upcoming Investor Conferences |
| 2026-02-12 | Press release | Biodesix to Report Fourth Quarter and Full Year 2025 Financial Results on |
| 2026-01-12 | Press release | Biodesix Announces Preliminary Fourth Quarter and Full-Year 2025 Results (Unaudited) |
| 2026-01-12 | 8-K | Form 8-K/A, Item 2.02 results |
| 2025-11-03 | Press release | Biodesix Announces Third Quarter 2025 Results and Highlights |
| 2025-11-03 | 8-K | Form 8-K, Item 2.02 results |
| 2025-11-03 | 10-Q | Form 10-Q for the quarter ended Sep 30 |
| 2025-10-01 | 8-K | Form 8-K, Item 8.01 |
| 2025-09-15 | 8-K | Form 8-K, Item 3.03 |
| 2025-09-11 | 8-K | Form 8-K, Item 8.01 |
| 2025-08-07 | Press release | Biodesix Announces Second Quarter 2025 Results and Highlights |
| 2025-08-07 | 8-K | Form 8-K, Item 2.02 results |
| 2025-08-07 | 10-Q | Form 10-Q for the quarter ended Jun 30 |
| 2025-05-21 | 8-K | Form 8-K, Item 5.07 |
| 2025-05-13 | Press release | Biodesix Announces First Quarter 2025 Results and Highlights |
| 2025-05-13 | 8-K | Form 8-K, Item 2.02 results |
| 2025-05-13 | 10-Q | Form 10-Q for the quarter ended Mar 31 |
| 2025-04-28 | Proxy | Definitive proxy statement |
| 2025-04-17 | 8-K | Form 8-K, Item 5.02 |